Charles Cantor has joined InSilico Medicine's scientific advisory board and will serve as its chair. Cantor co-founded Sequenom and is a professor emeritus at Boston University, distinguished adjunct professor at the University of California, Irvine, and an adjunct professor at the Moscow Institute of Physics and Technology and also at Scripps Research Institute. He was previously the chair and professor of the department of biomedical engineering and biophysics and director of the Center for Advanced Biotechnology at Boston University.
Exosome Diagnostics has named William Kelly as CFO.
Kelly has worked for RepliGen for the past six years, serving as the principal financial officer there for more than five years. He has also served as corporate controller of Haemonetics, and has worked for Deloitte & Touche.
Caris Life Sciences has promoted Sandeep Reddy to chief medical officer. He was previously senior medical director at Caris. In his new role, he will lead the company's research efforts through the Caris Research Institute and guide strategy for the deployment of Caris' precision medicine tools in the clinical setting.